Zobrazeno 1 - 10
of 15
pro vyhledávání: '"P. S. Semenovykh"'
Publikováno v:
Український Журнал Нефрології та Діалізу, Iss 4(40) (2017)
Introduction. Monocyte chemoattractant protein type 1 (MCP-1) and plasminogen activator inhibitor type 1 (PAI-1) play a key role in inflammation, fibrosis and progression of renal dysfunction. Sulodexide advantages in vascular pathology treatment wer
Externí odkaz:
https://doaj.org/article/a06858196f1548f99af7f66a453e40e1
Publikováno v:
Ukrainian Therapeutical Journal. :48-60
Objective — to reveal an association of I/D polymorphism of ACE gene with metabolic factors of cardiovascular risk (CVR) such as visceral obesity (VO), insulin resistance (IR), dyslipidemia (DLP) as well as with indices characterized structural and
Publikováno v:
Ukrainian Therapeutical Journal. :39-43
Objective — to determine the prevalence of the Alu Ins/Del polymorphism of the angiotensin‑converting enzyme (ACE) gene in patients with type 2 diabetes mellitus (DM 2) with nephropathy and to identify possible associative relationship between th
Publikováno v:
Ukraïnsʹkij žurnal medicini, bìologìï ta sportu. 6:192-198
Diabetic kidney disease develops in approximately 40% of patients who are diabetic and is the leading cause of chronic kidney disease worldwide. The majority of patients actually die from cardiovascular diseases and infections before needing kidney r
Publikováno v:
Ukrainian Journal of Nephrology and Dialysis. :11-18
The present study aimed to investigate the dynamics of clinical and laboratory parameters and serum Klotho protein level in patients with diabetic kidney disease using nephroprotective therapy combined with an inhibitor of the sodium-glucose cotransp
Publikováno v:
Ukrainian Therapeutical Journal. :15-21
Objective — to determine serum level of vascular endothelial growth factor (VEGF) in patients with diabetic nephropathy (DN) — carriers of different genotypes of Klotho gene polymorphism in different stages of the disease and in the treatment dyn
Publikováno v:
Ukrainian Therapeutical Journal. :18-24
Autor:
I. I. Topchii, T. D. Shcherban, Yu. S. Yakimenko, P. S. Semenovykh, V. V. Masiy, A. N. Kirienko
Publikováno v:
Ukraïnsʹkij žurnal medicini, bìologìï ta sportu. 3:154-158
Publikováno v:
Український Журнал Нефрології та Діалізу, Iss 4(48), Pp 26-30 (2017)
Apoptosis, programmed cell death, regarded as one of the main mechanisms of glomerulosclerosis in diabetic nephropathy (DN). The aim of the present researchto study the effects of actovegin on cell apoptosis in patients with DN. Materials and methods
Publikováno v:
Український Журнал Нефрології та Діалізу, Iss 1(45), Pp 25-30 (2014)
Introduction. Recent studies suggest that visfatin participates in pathogenesis of vascular diabetic complications, in particular diabetic nephropathy (DN). The aim of the present research - definition of visfatin level in peripheral blood of type 2